Globe Life is a financial services holding company that operates through its wholly owned subsidiaries providing life insurance, annuity, and supplemental health insurance products. The company is based in McKinney, Texas.
| Revenue (TTM) | $6.19B |
| Gross Profit (TTM) | $2.10B |
| EBITDA | $1.68B |
| Operating Margin | 24.60% |
| Return on Equity | 20.90% |
| Return on Assets | 3.36% |
| Revenue/Share (TTM) | $78.36 |
| Book Value | $79.89 |
| Price-to-Book | 2.11 |
| Price-to-Sales (TTM) | 2.10 |
| EV/Revenue | 2.535 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 19.70% |
| Quarterly Revenue Growth (YoY) | 8.00% |
| Shares Outstanding | $76.85M |
| Float | $76.14M |
| % Insiders | 0.70% |
| % Institutions | 87.33% |
Volatility is currently expanding
Globe Life (GL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Globe Life Inc. demonstrates consistent earnings growth, robust buybacks, and disciplined dividend increases, targeting underserved middle-income markets. GL's Q2 2026 net operating income per share rose 10.4% year-over-year, with a 14.3% ROE and aggressive share repurchases below fair value. A new $2.5 billion buyback authorization and a secure, fast-growing dividend (10–12% annually) underpin a compelling long-term total return profile.
GL's health business is accelerating premium growth, led by United American and Family Heritage, while adding diversification beyond life insurance.
Globe Life expects premium growth, AI adoption and distribution expansion to support earnings, while strong capital enables substantial share buybacks.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
GL's health business gains momentum from strong premium growth, rate increases and expanding distribution, though medical inflation poses risks.
Globe Life (GL) reported earnings 30 days ago. What's next for the stock?
GL's premium growth, rising investment income and AI initiatives support earnings, while higher health claims remain a risk.
Accident and Health Insurance stocks like AFL, GL, TRUP and EIG are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.
MCKINNEY, Texas, Aug. 10, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE:GL) announced a new authorization, effective August 15, 2026, to repurchase up to $2.5 billion of common stock in the future under the Company's existing share repurchase program. This authorization was approved by Globe Life's Board of Directors during its regular quarterly board meeting on August 5, 2026, and replaces any previous authorizations.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on GL and any ticker you trade — then tracks every position and per-strategy win rate.
